海南板塊全線上漲 海南自貿港建設總體方案落地
格隆匯6月2日丨A股海南板塊全線上漲,其中,海德股份、大東海A、華聞集團漲停,洲際油氣逼近漲停,康芝藥業、海南瑞澤、海南海藥、京糧控股、雙成藥業、海汽集團、羅牛山等均明顯上漲。中共中央、國務院印發《海南自由貿易港建設總體方案》提出,大力發展旅遊業、現代服務業和高新技術產業,不斷夯實實體經濟基礎,增強產業競爭力。到2025年,初步建立以貿易自由便利和投資自由便利為重點的自由貿易港政策制度體系。中信證券稱,海南自貿港離島免税額度由3萬提高至10萬、鼓勵類企業所得税率降至15%、人才個人所得税率不超過15%、島內居民基於正面清單免税購買進境商品等等,利好當地免税和旅遊產業打開發展空間。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.